SaratogaRIM Large Cap Quality Focus (S:0P00014GB9)
32.29
-0.90
(-2.72%)
USD |
Oct 31 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
| Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
|---|---|---|---|
| -- | -- | -- | -- |
| Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
| Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Adam Sato | 10.18 yrs |
| Joseph Pollard | 10.18 yrs |
| Kevin Tanner | 10.18 yrs |
| Marc Crosby | 10.18 yrs |
| Matthew Casas | 10.18 yrs |
| Philip Spencer | 10.18 yrs |
| Robert Meng | 10.18 yrs |
| Andrew Early | 7.42 yrs |
| Mathew Spencer | 5.59 yrs |
| Matt Keating | 5.59 yrs |
Annual Total Returns Versus Peers
As of November 13, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| RTX Corp | 7.32% | 123.37 | -0.96% |
| Oracle Corp | 6.79% | 189.54 | 0.22% |
| Unilever PLC ADR | 6.77% | 57.56 | -1.15% |
| Microsoft Corp | 6.18% | 423.02 | 1.20% |
| The Walt Disney Co | 6.11% | 101.02 | 0.16% |
| Alphabet Inc Class A | 5.94% | 181.60 | 0.69% |
| Berkshire Hathaway Inc Class B | 5.86% | 466.27 | -0.23% |
| Medtronic PLC | 4.91% | 88.24 | -0.04% |
| Roche Holding AG ADR | 4.53% | 37.35 | -0.72% |
| Johnson & Johnson | 4.53% | 152.67 | -1.53% |
Fees & Availability
| Fees | |
| Negotiable Fee | No |
| Administrative Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Trustee Fee | -- |
| Purchase Details | |
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Equity Style | |
| Fixed Income Style | |
| Broad Asset Class | |
| Broad Category | |
| Category Name | |
| Category Index | |
| Global Category Name | |
| YCharts Categorization | US Large Cap Blend |
| YCharts Benchmark | S&P 500 Total Return (^SPXTR) |
| Fund Owner Firm Name | |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| 100.0% | |
| Manager Tenure | |
| Adam Sato | 10.18 yrs |
| Joseph Pollard | 10.18 yrs |
| Kevin Tanner | 10.18 yrs |
| Marc Crosby | 10.18 yrs |
| Matthew Casas | 10.18 yrs |
| Philip Spencer | 10.18 yrs |
| Robert Meng | 10.18 yrs |
| Andrew Early | 7.42 yrs |
| Mathew Spencer | 5.59 yrs |
| Matt Keating | 5.59 yrs |
Fundamentals
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Forecasted Dividend Yield | -- |
| Forecasted PE Ratio | -- |
| Forecasted Price to Sales Ratio | -- |
| Forecasted Price to Book Ratio | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |